Form 4 for LAB STANDARD BIOTOOLS INC.
Accepted 2022-04-13 00:00:00 ET · period of report 2022-04-11 · accession 0000902664-22-002542 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2022-04-13 | 2022-04-11+ | LAB | Caligan Partners LP | 10% | P - Purchase | $3.80 | +195.0K | 9.03M | +2% | +$741.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-12 | P | A | 50,000 | $3.60 | 9,084,838 | I See footnote | — | — | (F1) The securities reported herein are held by an affiliated fund and managed account of Caligan Partners LP ("Caligan"). David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan. |
| 2 | Common | Common Stock, $0.001 par value per share ("Common Stock") | 2022-04-11 | P | A | 145,000 | $3.87 | 9,034,838 | I See footnote | — | — | (F1) The securities reported herein are held by an affiliated fund and managed account of Caligan Partners LP ("Caligan"). David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan. |